CDKN2A and head and neck squamous cell carcinoma: In HNSCC, homozygous deletion or mutation of CDKN2A (encoding the p16 protein) is observed in 58% of patients, and amplification of CCND1 (encoding the Cyclin D1 protein) is observed in 31% of patients6.